Back
Veeva Systems 10K Form
Sell
42
VEEV
Veeva Systems
Last Price:
212.58
Seasonality Move:
1.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2023-09-01 | 10Q | VEEV/Veeva Systems Quarterly |
2023-06-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-12-07 | 10Q | VEEV/Veeva Systems Quarterly |
2022-09-02 | 10Q | VEEV/Veeva Systems Quarterly |
2022-06-03 | 10Q | VEEV/Veeva Systems Quarterly |
Receive VEEV News And Ratings
See the #1 stock for the next 7 days that we like better than VEEV
VEEV Financial Statistics
Sales & Book Value
Annual Sales: | $2.36B |
---|---|
Cash Flow: | $92.87M |
Price / Cash Flow: | 35.04 |
Annual Sales: | $32.04 |
Price / Book: | 6.64 |
Profitability
EPS (TTM): | 3.75000 |
---|---|
Net Income (TTM): | $615.26M |
Gross Margin: | $1.69B |
Return on Equity: | 13.23% |
Return on Assets: | 10.65% |
Veeva Systems Earnings Forecast
Key Veeva Systems Financial Ratios
- The Gross Profit Margin over the past 14 years for VEEV is 71.35%.
- The Selling, General & Administrative Expenses for VEEV have been equal to 26.57% of Gross Profit Margin.
- The Research & Development expenses have been 26.61% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of VEEV is 22.24% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 12 years.
Veeva Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | VEEV |
CUSIP: | 922475 |
Website: | veeva.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.01 |
Quick Ratio: | 4.94 |
Price-to-Earnings
Trailing P/E Ratio: | 66 |
---|---|
Forward P/E Ratio: | 31.12 |
VEEV Technical Analysis vs Fundamental Analysis
Sell
42
Veeva Systems (VEEV)
is a Sell
Is Veeva Systems a Buy or a Sell?
-
Veeva Systems stock is rated a Sell
The current Veeva Systems [VEEV] share price is $212.53. The Score for VEEV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.